LOS ANGELES — A focus of researchers at Ronald Reagan UCLA Medical Center is hospital-acquired infections (HAIs), and on July 9 the medical center announced that it had received a $2.5 million grant to aid research, according to the Examiner.
The funds are provided by an RO1 grant (HS021188-01) from the Agency for Healthcare Research and Quality, a component of the U.S. Department of Health and Human Services, the article stated.
According to the article, UCLA researchers will use the funds to conduct one of the first randomized clinical trials to determine if the reduction of surface bacteria due to the use of copper will result in a decreased number of HAIs.
The multidisciplinary project will be conducted by the UCLA Sustainable Technology and Policy Program, and will involve teams from the David Geffen School of Medicine at UCLA, the UCLA Fielding School of Public Health and the Henry Samueli School of Engineering and Applied Science, the article noted.
"We will be studying if lowering the level of bacteria on hospital surfaces results in reduced infection rates in patients, better outcomes and even lower costs," explained the project''s principal investigator, Dr. Daniel Uslan, director of the antimicrobial stewardship program at the medical school and an assistant clinical professor of medicine in the division of infectious diseases.
Click here to read the complete article.